Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
SURGERY	O
Allergies:	O
Tetracycline	O
Analogues	O
/	O
Streptomycin	O
/	O
Ciprofloxacin	O
/	O
Penicillin	O
V	O
Potassium	O
/	O
Vicodin	O
/	O
Iodine	O
/	O
NSAIDS	O
(Non-Steroidal	O
Anti-Inflammatory	O
Drug)	O
/	O
angiogram	O
dye	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Cholelithiasis	O
status	O
post	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
for	O
choledocholithiasis.	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Open	O
cholecystectomy	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
female	O
with	O
multiple	O
medical	O
co-morbidities	O
who	O
recently	O
underwent	O
ERCP	O
for	O
choledocholithiasis.	O
She	O
started	O
having	O
intermittent	O
epigastric	O
pain	O
2	O
weeks	O
ago,	O
radiating	O
to	O
bilateral	O
sides	O
and	O
back.	O
The	O
pain	O
was	O
unrelated	O
to	O
food	O
and	O
had	O
initially	O
resolved	O
after	O
ERCP	O
(as	O
had	O
her	O
LFTs)	O
however	O
some	O
mild	O
pain	O
did	O
restart.	O
She	O
was	O
tolerating	O
a	O
regular	O
diet	O
with	O
no	O
nausea	O
or	O
vomiting.	O
She	O
had	O
no	O
prior	O
episodes	O
and	O
no	O
episodes	O
of	O
cholecystitis.	O
She	O
denied	O
fever/chills.	O
Past	O
Medical	O
History:	O
PMH:	O
-	O
COPD,	O
continues	O
to	O
smoke,	O
not	O
on	O
home	O
oxygen	O
-	O
H/o	O
pulmonary	O
nodules	O
followed	O
for	O
several	O
years	O
-	O
CAD	O
s/p	O
CABG	O
(4	O
vessel	O
in	O
___,	O
one	O
vessel	O
occluded	O
on	O
cath	O
___,	O
no	O
stents)	O
-	O
Perforated	O
ulcer	O
-	O
___	O
ex-lap,	O
was	O
H	O
pylori	O
positive	O
-	O
Uterine	O
CA	O
-s/p	O
TAH	O
BSO	O
-	O
___	O
years	O
ago	O
PSH:	O
-	O
CABG	O
(___)	O
-	O
Appendectomy	O
-	O
Tonsillectomy	O
-	O
Bladder	O
suspension	O
procedure	O
-	O
Eye	O
surgery	O
x	O
3	O
-	O
TAH/BSO	O
___	O
years	O
ago)	O
-	O
Ex-lap	O
for	O
perforated	O
ulcer	O
repair	O
(___)	O
Social	O
History:	O
___	O
Family	O
History:	O
Breast/ovarian	O
cancer	O
Physical	O
Exam:	O
Upon	O
Discharge:	O
Vitals	O
-	O
98.1	O
98.0	O
96	O
150/86	O
22	O
95%3L	O
Gen	O
-	O
AAOx3,	B-Delirium
NAD	O
CV	O
-	O
+S1/S2,	O
no	O
murmurs/rubs/gallops	O
Resp	O
-	O
distant	O
breath	O
sounds	O
bilaterally,	O
diffuse	O
occasional	O
coarse	O
breath	O
sounds	O
and	O
crackles	O
diffusely,	O
no	O
wheezes/rhonchi	O
Abd	O
-	O
soft,	O
non-tender,	O
non-distended,	O
+BS,	O
no	O
rebound/rigidity/guarding,	O
no	O
palpable	O
masses	O
Inc	O
-	O
clean/dry/intact,	O
no	O
erythema/drainage/induration	O
Ext	O
-	O
no	O
cyanosis/clubbing/edema	O
Pertinent	O
Results:	O
OPERATIVE	O
PATHOLOGY	O
(___):	O
Gall	O
bladder,	O
cholecystectomy:	O
adenocarcinoma	O
of	O
the	O
gallbladder	O
with	O
associated	O
high-grade	O
dysplasia.	O
BILATERAL	O
LOWER	O
EXTREMITY	O
ULTRASOUND	O
(___):	O
No	O
DVT	O
in	O
both	O
lower	O
extremities.	O
CHEST	O
X-RAY	O
(___):	O
Enlargement	O
of	O
the	O
peripheral	O
consolidative	O
abnormality	O
at	O
the	O
left	O
lung	B-Lower_respiratory_tract_infection
base	O
since	O
___	O
is	O
consistent	O
with	O
increasing	O
infection	B-Lower_respiratory_tract_infection
or	O
infarction.	O
These	O
diagnostic	O
possibilities	O
were	O
discussed	O
by	O
Dr.	O
___	O
with	O
the	O
physician	O
caring	O
for	O
this	O
patient	O
at	O
approximately	O
11:30	O
this	O
morning.	O
Mild	O
edema	O
persists	O
at	O
the	O
base	O
of	O
the	O
right	O
lung.	O
Heart	O
size	O
is	O
normal.	O
V/Q	O
SCAN	O
(___):	O
Low	O
likelihood	O
ratio	O
for	O
recent	O
pulmonary	O
embolism.	O
Matched	O
defects	O
in	O
both	O
lung	O
relate	O
to	O
COPD.	O
CHEST	O
X-RAY	O
(___):	O
Left	O
lower	O
lobe	O
opacification	O
with	O
associated	O
pleural	O
effusion,	O
consistent	O
with	O
pneumonia	B-Lower_respiratory_tract_infection
in	O
the	O
appropriate	O
clinical	O
setting.	O
LABS	O
UPON	O
DISCHARGE:	O
___	O
04:33AM	O
BLOOD	O
WBC-8.6	O
RBC-3.03*	O
Hgb-10.2*	O
Hct-30.6*	O
MCV-101*	O
MCH-33.8*	O
MCHC-33.5	O
RDW-13.3	O
Plt	O
___	O
___	O
04:33AM	O
BLOOD	O
Plt	O
___	O
___	O
04:33AM	O
BLOOD	O
Glucose-103*	O
UreaN-7	O
Creat-0.4	O
Na-134	O
K-4.0	O
Cl-100	O
HCO3-24	O
AnGap-14	O
___	O
01:42AM	O
BLOOD	O
ALT-18	O
AST-22	O
AlkPhos-74	O
Amylase-18	O
TotBili-0.9	O
___	O
04:33AM	O
BLOOD	O
Calcium-8.0*	O
Phos-3.3	O
Mg-1.9	O
Brief	O
Hospital	O
Course:	O
The	O
patient	O
was	O
admitted	O
to	O
the	O
General	O
Surgical	O
Service	O
for	O
evaluation	O
and	O
treatment.	O
On	O
___,	O
the	O
patient	O
underwent	O
an	O
open	O
cholecystectomy,	O
which	O
went	O
well	O
without	O
complication	O
(reader	O
referred	O
to	O
the	O
Operative	O
Note	O
for	O
details).	O
The	O
patient	O
was	O
given	O
an	O
epidural	O
for	O
pain	O
control,	O
which	O
controlled	O
her	O
pain	O
well.	O
However,	O
in	O
the	O
PACU,	O
the	O
patient	O
required	O
a	O
transient	O
phenylephrine	O
drip,	O
2	O
L	O
fluid	O
bolus,	O
and	O
one	O
dose	O
of	O
albumin	O
due	O
to	O
a	O
systolic	O
blood	O
pressure	O
in	O
the	O
___,	O
while	O
mentating	O
well	O
and	O
being	O
entirely	O
asymptomatic.	O
Of	O
note,	O
the	O
patient	O
had	O
taken	O
her	O
HTN	O
medications	O
that	O
morning.	O
With	O
adjustment	O
of	O
the	O
epidural	O
parameters,	O
the	O
patient	O
was	O
easily	O
weaned	O
off	O
the	O
phenylephrine,	O
with	O
stable	O
blood	O
pressures	O
in	O
the	O
90-100s.	O
Thereafter,	O
she	O
was	O
trasnferred	O
to	O
the	O
general	O
surgical	O
floor	O
with	O
a	O
foley	O
catheter,	O
NPO,	O
on	O
IVF,	O
with	O
a	O
foley	O
catheter	O
and	O
JP	O
drain.	O
The	O
patient	O
was	O
hemodynamically	O
stable.	O
General	O
Brief	O
Hospital	O
Course:	O
Neuro:	O
The	O
patient	O
orgiginally	O
received	O
an	O
epidural	O
on	O
POD1,	O
however,	O
it	O
did	O
not	O
control	O
her	O
pain,	O
the	O
epidural	O
was	O
split	O
and	O
then	O
discontinued	O
on	O
POD2	O
at	O
which	O
point	O
the	O
patient	O
was	O
transistioned	O
to	O
oral	O
pain	O
medication	O
with	O
IV	O
breakthrough.	O
When	O
tolerating	O
oral	O
intake,	O
the	O
patient	O
was	O
successfully	O
transitioned	O
to	O
oral	O
pain	O
medications,	O
and	O
had	O
good	O
pain	O
control	O
thereafter.	O
CV:	O
The	O
patient	O
remained	O
stable	O
from	O
a	O
cardiovascular	O
standpoint	O
after	O
transfer	O
from	O
the	O
PACU	O
to	O
the	O
floor;	O
vital	O
signs	O
were	O
routinely	O
monitored.	O
Of	O
note	O
an	O
a-line	O
was	O
placed	O
briefly	O
while	O
the	O
patient	O
was	O
in	O
the	O
ICU	O
to	O
monitor	O
hemodynamics.	O
a-line	O
was	O
discontinued	O
on	O
POD4	O
as	O
patients	O
hemodynamics	O
remained	O
stable	O
throughout	O
the	O
rest	O
of	O
her	O
hospital	O
stay.	O
Pulmonary:	O
On	O
POD2	O
patient	O
has	O
an	O
episode	O
of	O
desaturation	O
to	O
the	O
mid	O
70's	O
which	O
was	O
transient	O
and	O
imporved	O
with	O
IS	O
usage	O
and	O
O2	O
per	O
nasal	O
cannula.	O
Patient	O
experienced	O
another	O
episode	O
of	O
desaturation	O
to	O
the	O
70's	O
which	O
also	O
responded	O
to	O
supplemental	O
oxygen	O
however,	O
this	O
episode	O
was	O
associated	O
with	O
a	O
change	B-Delirium
in	B-Delirium
mental	B-Delirium
status.	B-Delirium
Pateint	O
was	O
hemodynamicaly	O
stable,	O
O2	O
saturation	O
remained	O
above	O
90	O
with	O
supplemental	O
oxygen	O
and	O
UOP	O
was	O
sufficient.	O
WBC	O
was	O
however	O
elevated	O
at	O
18	O
and	O
the	O
decision	O
was	O
made	O
to	O
transfer	O
the	O
patient	O
to	O
the	O
ICU	O
for	O
a	O
further	O
w/u	O
of	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
Blood	O
gases	O
were	O
followed	O
closely	O
and	O
the	O
patient	O
was	O
continued	O
on	O
supplemental	O
oxygen.	O
ABGs	O
remained	O
consistent	O
with	O
a	O
picture	O
of	O
chronic	O
COPD.	O
While	O
in	O
the	O
ICU	O
patient	O
remaine	O
stable	O
from	O
a	O
cardiovascular	O
standpoint,	O
however,	O
she	O
continued	O
to	O
have	O
episoded	O
of	O
altered	B-Delirium
mental	B-Delirium
status	B-Delirium
especially	O
in	O
the	O
evening.	O
Workup	O
(please	O
refer	O
to	O
Pertinent	O
Results	O
section)	O
proved	O
negative	O
for	O
pulmonary	O
embolism.	O
Imaging	O
and	O
clinical	O
correlation	O
was	O
suggestive	O
of	O
pneumonia,	B-Lower_respiratory_tract_infection
and	O
the	O
patient	O
was	O
treated	O
accordingly	O
(please	O
refer	O
to	O
ID	O
section	O
below).	O
GI/GU/FEN:	O
Post-operatively,	O
the	O
patient	O
was	O
made	O
NPO	O
with	O
IV	O
fluids.	O
Diet	O
was	O
advanced	O
when	O
appropriate,	O
which	O
was	O
well	O
tolerated.	O
Patient's	O
intake	O
and	O
output	O
were	O
closely	O
monitored,	O
and	O
IV	O
fluid	O
was	O
adjusted	O
when	O
necessary.	O
Electrolytes	O
were	O
routinely	O
followed,	O
and	O
repleted	O
when	O
necessary.	O
Once	O
appropriate	O
bowel	O
function	O
was	O
seen	O
to	O
return,	O
the	O
patient	O
was	O
transitioned	O
to	O
clear	O
liquids,	O
then	O
full	O
liquids,	O
and	O
finally	O
a	O
regular	O
diet.	O
She	O
tolerated	O
all	O
these	O
steps	O
well.	O
ID:	O
The	O
patient's	O
white	O
blood	O
count	O
and	O
fever	O
curves	O
were	O
closely	O
watched	O
for	O
signs	O
of	O
infection	O
throughout	O
her	O
stay.	O
As	O
discussed	O
above,	O
the	O
identification	O
of	O
pneumonia	B-Lower_respiratory_tract_infection
prompted	O
requesting	O
the	O
input	O
of	O
Infectious	O
Disease	O
specialists.	O
Per	O
their	O
recommendations,	O
the	O
patient	O
was	O
started	O
on	O
IV	O
vancomycin,	O
cefepime,	O
and	O
flagyl.	O
The	O
vancomycin	O
was	O
discontinued	O
after	O
2	O
days,	O
while	O
cefepime	O
and	O
flagyl	O
were	O
continued	O
through	O
till	O
discharge.	O
Please	O
note	O
that	O
per	O
recommendations,	O
the	O
patient	O
was	O
discharged	O
with	O
prescriptions,	O
and	O
clear	O
instructions	O
to	O
take	O
THREE	O
(3)	O
DAYS	O
of	O
antibiotics	O
after	O
discharge	O
as	O
follows:	O
Cefpodoxime	O
400	O
mg	O
PO	O
q12H,	O
and	O
Flagyl	O
500	O
mg	O
PO	O
q8H.	O
Endocrine:	O
The	O
patient's	O
blood	O
sugar	O
was	O
monitored	O
throughout	O
his	O
stay;	O
insulin	O
dosing	O
was	O
adjusted	O
accordingly.	O
Hematology:	O
The	O
patient's	O
complete	O
blood	O
count	O
was	O
examined	O
routinely;	O
no	O
transfusions	O
were	O
required.	O
Prophylaxis:	O
The	O
patient	O
received	O
subcutaneous	O
heparin	O
and	O
venodyne	O
boots	O
were	O
used	O
during	O
this	O
stay;	O
was	O
encouraged	O
to	O
get	O
up	O
and	O
ambulate	O
as	O
early	O
as	O
possible.	O
At	O
the	O
time	O
of	O
discharge,	O
the	O
patient	O
was	O
doing	O
well,	O
afebrile	O
with	O
stable	O
vital	O
signs.	O
The	O
patient	O
was	O
tolerating	O
a	O
regular	O
diet,	O
ambulating,	O
voiding	O
without	O
assistance,	O
and	O
pain	O
was	O
well	O
controlled.	O
The	O
patient	O
received	O
discharge	O
teaching	O
and	O
follow-up	O
instructions	O
with	O
understanding	O
verbalized	O
and	O
agreement	O
with	O
the	O
discharge	O
plan.	O
Based	O
upon	O
the	O
operative	O
pathology,	O
the	O
Liver	O
experts	O
and	O
Hematology/Oncology	O
team	O
were	O
consulted.	O
They	O
visited	O
the	O
patient,	O
and	O
recommended	O
further	O
follow-up	O
as	O
outpatient	O
to	O
make	O
further	O
plans.	O
The	O
patient	O
and	O
her	O
family	O
expressed	O
strongly	O
their	O
interest	O
in	O
completing	O
her	O
recovery	O
at	O
rehab,	O
and	O
pursuing	O
further	O
once	O
she	O
felt	O
more	O
physically	O
improved.	O
At	O
the	O
time	O
of	O
discharge,	O
the	O
patient	O
was	O
doing	O
well,	O
afebrile	O
with	O
stable	O
vital	O
signs.	O
The	O
patient	O
was	O
tolerating	O
a	O
regular	O
diet,	O
ambulating,	O
voiding	O
without	O
assistance,	O
and	O
pain	O
was	O
well	O
controlled.	O
The	O
patient	O
received	O
discharge	O
teaching	O
and	O
follow-up	O
instructions	O
with	O
understanding	O
verbalized	O
and	O
agreement	O
with	O
the	O
discharge	O
plan.	O
Medications	O
on	O
Admission:	O
Atorvastatin	O
80	O
mg	O
po	O
daily	O
Fluticasone	O
spray	O
PRN	O
Isosorbide	O
mononitrate	O
ER	O
60	O
mg	O
po	O
daily	O
Metoprolol	O
tartarate	O
100	O
mg	O
2	O
tabs	O
BID	O
Nitroglycerin	O
PRN	O
Olopatadine	O
0.2%	O
eye	O
drops	O
1	O
drop	O
to	O
both	O
eyes	O
daily	O
Prednisolone	O
acetate	O
1%	O
eye	O
drop	O
to	O
both	O
eyes	O
4x	O
per	O
day	O
Vitamin	O
B-12	O
Omeprazole	O
20	O
mg	O
po	O
daily	O
Discharge	O
Medications:	O
1.	O
Atorvastatin	O
80	O
mg	O
PO	O
DAILY	O
2.	O
Fluticasone	O
Propionate	O
NASAL	O
1	O
SPRY	O
NU	O
BID:PRN	O
PRN	O
3.	O
Isosorbide	O
Mononitrate	O
60	O
mg	O
PO	O
DAILY	O
4.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
PRN	O
chest	O
pain	O
5.	O
olopatadine	O
*NF*	O
0.2	O
%	O
___	O
daily	O
6.	O
PrednisoLONE	O
Acetate	O
1%	O
Ophth.	O
Susp.	O
1	O
DROP	O
BOTH	O
EYES	O
QID	O
7.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
8.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
fever/pain	O
RX	O
*acetaminophen	O
650	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
six	O
(6)	O
hours	O
Disp	O
#*40	O
Tablet	O
Refills:*0	O
9.	O
Cefpodoxime	O
Proxetil	O
400	O
mg	O
PO	O
Q12H	O
Duration:	O
4	O
Days	O
RX	O
*cefpodoxime	O
200	O
mg	O
2	O
tablet(s)	O
by	O
mouth	O
every	O
twelve	O
(12)	O
hours	O
Disp	O
#*16	O
Tablet	O
Refills:*0	O
10.	O
MetRONIDAZOLE	O
(FLagyl)	O
500	O
mg	O
PO	O
TID	O
Duration:	O
4	O
Days	O
RX	O
*metronidazole	O
500	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
eight	O
(8)	O
hours	O
Disp	O
#*12	O
Tablet	O
Refills:*0	O
11.	O
Fluticasone-Salmeterol	O
Diskus	O
(100/50)	O
1	O
INH	O
IH	O
BID	O
12.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
Hold	O
for	O
SBP<100,	O
P<60.	O
13.	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q6H	O
wheezing	O
Please	O
perform	O
Chest	O
___	O
after	O
each	O
Neb	O
14.	O
OxycoDONE	O
(Immediate	O
Release)	O
___	O
mg	O
PO	O
Q4H:PRN	O
pain	O
RX	O
*oxycodone	O
5	O
mg	O
___	O
tablet(s)	O
by	O
mouth	O
every	O
four	O
(4)	O
hours	O
Disp	O
#*40	O
Tablet	O
Refills:*0	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Cholelithiasis	O
status	O
post	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
for	O
choledocholithiasis.	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
to	O
the	O
surgery	O
service	O
at	O
___	O
for	O
surgical	O
management	O
of	O
your	O
cholelithiasis.	O
You	O
have	O
done	O
well	O
in	O
the	O
post	O
operative	O
period	O
and	O
are	O
now	O
safe	O
to	O
complete	O
your	O
recovery	O
at	O
rehab	O
with	O
the	O
following	O
instructions:	O
Please	O
resume	O
all	O
regular	O
home	O
medications,	O
unless	O
specifically	O
advised	O
not	O
to	O
take	O
a	O
particular	O
medication.	O
Also,	O
please	O
take	O
any	O
new	O
medications	O
as	O
prescribed.	O
Please	O
get	O
plenty	O
of	O
rest,	O
continue	O
to	O
ambulate	O
several	O
times	O
per	O
day,	O
and	O
drink	O
adequate	O
amounts	O
of	O
fluids.	O
Avoid	O
lifting	O
weights	O
greater	O
than	O
___	O
lbs	O
until	O
you	O
follow-up	O
with	O
your	O
surgeon,	O
who	O
will	O
instruct	O
you	O
further	O
regarding	O
activity	O
restrictions.	O
Avoid	O
driving	O
or	O
operating	O
heavy	O
machinery	O
while	O
taking	O
pain	O
medications.	O
Please	O
follow-up	O
with	O
your	O
surgeon	O
and	O
Primary	O
Care	O
Provider	O
(PCP)	O
as	O
advised.	O
Incision	O
Care:	O
*Please	O
call	O
your	O
doctor	O
or	O
nurse	O
practitioner	O
if	O
you	O
have	O
increased	O
pain,	O
swelling,	O
redness,	O
or	O
drainage	O
from	O
the	O
incision	O
site.	O
*Avoid	O
swimming	O
and	O
baths	O
until	O
your	O
follow-up	O
appointment.	O
*You	O
may	O
shower,	O
and	O
wash	O
surgical	O
incisions	O
with	O
a	O
mild	O
soap	O
and	O
warm	O
water.	O
Gently	O
pat	O
the	O
area	O
dry.	O
*If	O
you	O
have	O
staples,	O
they	O
will	O
be	O
removed	O
at	O
your	O
follow-up	O
appointment.	O
*If	O
you	O
have	O
steri-strips,	O
they	O
will	O
fall	O
off	O
on	O
their	O
own.	O
Please	O
remove	O
any	O
remaining	O
strips	O
___	O
days	O
after	O
surgery.	O
Please	O
call	O
your	O
doctor	O
or	O
nurse	O
practitioner	O
if	O
you	O
experience	O
the	O
following:	O
*You	O
experience	O
new	O
chest	O
pain,	O
pressure,	O
squeezing	O
or	O
tightness.	O
*New	O
or	O
worsening	O
cough,	O
shortness	O
of	O
breath,	O
or	O
wheeze.	O
*If	O
you	O
are	O
vomiting	O
and	O
cannot	O
keep	O
down	O
fluids	O
or	O
your	O
medications.	O
*You	O
are	O
getting	O
dehydrated	O
due	O
to	O
continued	O
vomiting,	O
diarrhea,	O
or	O
other	O
reasons.	O
Signs	O
of	O
dehydration	O
include	O
dry	O
mouth,	O
rapid	O
heartbeat,	O
or	O
feeling	O
dizzy	O
or	O
faint	O
when	O
standing.	O
*You	O
see	O
blood	B-Lower_gastrointestinal_haemorrhage
or	O
dark/black	B-Lower_gastrointestinal_haemorrhage
material	O
when	O
you	O
vomit	O
or	O
have	O
a	O
bowel	B-Lower_gastrointestinal_haemorrhage
movement.	O
*You	O
experience	O
burning	O
when	O
you	O
urinate,	O
have	O
blood	O
in	O
your	O
urine,	O
or	O
experience	O
a	O
discharge.	O
*Your	O
pain	O
is	O
not	O
improving	O
within	O
___	O
hours	O
or	O
is	O
not	O
gone	O
within	O
24	O
hours.	O
Call	O
or	O
return	O
immediately	O
if	O
your	O
pain	O
is	O
getting	O
worse	O
or	O
changes	O
location	O
or	O
moving	O
to	O
your	O
chest	O
or	O
back.	O
*You	O
have	O
shaking	O
chills,	O
or	O
fever	O
greater	O
than	O
101.5	O
degrees	O
Fahrenheit	O
or	O
38	O
degrees	O
Celsius.	O
*Any	O
change	O
in	O
your	O
symptoms,	O
or	O
any	O
new	O
symptoms	O
that	O
concern	O
you.	O
Followup	O
Instructions:	O
___	O

